Cell surface carbohydrates as prognostic markers in human carcinomas - PubMed (original) (raw)
Review
Cell surface carbohydrates as prognostic markers in human carcinomas
E Dabelsteen. J Pathol. 1996 Aug.
Abstract
Tumour development is usually associated with changes in cell surface carbohydrates. These are often divided into changes related to terminal carbohydrate structures, which include incomplete synthesis and modification of normally existing carbohydrates, and changes in the carbohydrate core structure. The latter includes chain elongation of both glycolipids and proteins, increased branching of carbohydrates in N-linked glycoproteins, and blocked synthesis of carbohydrates in O-linked mucin-like glycoproteins. In mature organisms, expression of distinct carbohydrates is restricted to specific cell types; within a given tissue, variation in expression may be related to cell maturation. Tumour-associated carbohydrate structures often reflect a certain stage of cellular development; most of these moieties are structures normally found in other adult or embryonic tissues. There is no unique tumour carbohydrate structure, since certain structures which are tumour-related in one organ may be normal constituents of other tissues. Tumour-associated carbohydrate changes have been used in the diagnosis of human cancers. Recently, however, it has been demonstrated that the expression of some carbohydrate structures is associated with prognosis. Tn, sialyl-Tn, and T are cell membrane-bound mucin-like carbohydrate structures that may be expressed in tumours due to blocked synthesis of the core carbohydrate chain of mucin-like structures. Their expression is strongly associated with prognosis in certain tumours, but the biological relationship between their expression and tumour progression is at present unknown. The blood group-related carbohydrate structures Le(x), sialyl-Le(x), ABH, and Le(y) are examples of terminal carbohydrate structures which are related to tumour prognosis. These structures are of increasing interest since they may function as adhesion molecules; adhesion of tumour cells to endothelial cells of blood vessels may be mediated by an interaction between sialosyl-Le(x) and E-selectin and studies indicate that Le(y) is related to cell motility. These findings are now the basis for tumour therapeutic experiments.
Similar articles
- Carbohydrate changes in colon carcinoma.
Itzkowitz S. Itzkowitz S. APMIS Suppl. 1992;27:173-80. APMIS Suppl. 1992. PMID: 1381596 Review. - [Tumor-associated carbohydrate antigens related to blood group carbohydrates].
Hirohashi S. Hirohashi S. Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1395-401. Gan To Kagaku Ryoho. 1986. PMID: 3729459 Japanese. - [Carbohydrate antigens and cancer].
Dabelsteen E, Mandel U, Clausen H. Dabelsteen E, et al. Ugeskr Laeger. 1993 Apr 26;155(17):1270-5. Ugeskr Laeger. 1993. PMID: 8506573 Review. Danish. - Carbohydrate changes in squamous cell carcinomas.
Dabelsteen E, Clausen H, Mandel U. Dabelsteen E, et al. APMIS Suppl. 1992;27:130-8. APMIS Suppl. 1992. PMID: 1520522 Review.
Cited by
- Serum antibody screening using glycan arrays.
Marglous S, Brown CE, Padler-Karavani V, Cummings RD, Gildersleeve JC. Marglous S, et al. Chem Soc Rev. 2024 Mar 4;53(5):2603-2642. doi: 10.1039/d3cs00693j. Chem Soc Rev. 2024. PMID: 38305761 Review. - Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies.
Mondal UK, Barchi JJ Jr. Mondal UK, et al. Front Chem. 2022 Oct 10;10:1002146. doi: 10.3389/fchem.2022.1002146. eCollection 2022. Front Chem. 2022. PMID: 36300019 Free PMC article. - Prognostic and Therapeutic Role of CD15 and CD15s in Cancer.
Szlasa W, Wilk K, Knecht-Gurwin K, Gurwin A, Froń A, Sauer N, Krajewski W, Saczko J, Szydełko T, Kulbacka J, Małkiewicz B. Szlasa W, et al. Cancers (Basel). 2022 Apr 28;14(9):2203. doi: 10.3390/cancers14092203. Cancers (Basel). 2022. PMID: 35565333 Free PMC article. Review. - A Stable Gold Nanoparticle-Based Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens.
Trabbic KR, Kleski KA, Barchi JJ Jr. Trabbic KR, et al. ACS Bio Med Chem Au. 2021 Dec 15;1(1):31-43. doi: 10.1021/acsbiomedchemau.1c00021. Epub 2021 Sep 10. ACS Bio Med Chem Au. 2021. PMID: 34927166 Free PMC article. - Mucins as anti-cancer targets: perspectives of the glycobiologist.
Brockhausen I, Melamed J. Brockhausen I, et al. Glycoconj J. 2021 Aug;38(4):459-474. doi: 10.1007/s10719-021-09986-8. Epub 2021 Mar 11. Glycoconj J. 2021. PMID: 33704667 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources